Transforming Vascular Access

HydroPICC® and HydroMID®

with MIMIX® Technology

Demonstrated Reduction in Complications*

 

We are solving the greatest challenges in vascular access.

Access Vascular is offering a suite of vascular access devices that use our novel, patented biomaterial featuring MIMIX® technology which is designed to prevent the most common and costly complications in vascular access.

  • Keep treatment moving forward with products that have demonstrated in clinical, in vivo and in vitro data to have a statistically significant reduction in complications compared to standard polyurethane catheters.*

  • Tackle most avoidable complications like occlusions and replacements - no coatings, fillers or surface modifications.

  • Provide better patient experience - fewer device replacements means fewer unnecessary needle sticks and fewer delays in treatment.

  • Potential savings of up to $1.8 million in reduced complications for a large acute care hospital based on economic study.

Comparison image Access Vascular catheter versus an anti-thrombogenic and anti-microbial catheter

MIMIX® TECHNOLOGY

Our hydrophilic biomaterial features MIMIX® technology which is designed to reduce thrombosis, a leading cause of multiple complications for indwelling catheters.

AVI PRODUCT FAMILY

Interested in adding the HydroPICC and HydroMID to your practice?

*No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained.